Category Archives: Industry

Industry news on LLLT, Low Level Laser Therapy, Cold Laser, Laser Biostimulation, LEPT Low Energy photon Therapy, LILT Low Intensity Laser therapy, Photobiomodulation, Photostimulation, Laser Therapy

Seven News – Photobiomodulation for chronic pain

Posted on 30 June 2019 by Ian

Dr Roberta Chow PhD and Lydia Feng talk about the use of light and lasers for relief of chronic pain. The THOR handheld unit and NovoTHOR light-pod can be used to reduce the need for medication and delay the need for surgery without any side-effects.

View current photobiomodulation therapy training dates in your location.

Posted in Industry, Interviews, Video of the Week | on Seven News – Photobiomodulation for chronic pain

Valeda Light Delivery System Receives 2019 Medical Design Excellence Award

Posted on 13 June 2019 by James Carroll

SEATTLE, June 12, 2019 /PRNewswire/ — LumiThera, Inc. and Product Creation Studio today announced that LumiThera’s Valeda Light Delivery System has been honored with a silver award in the 21st Annual Medical Design Excellence Awards competition. The 2019 winners were announced at the MDEA Ceremony on Tuesday, June 11, 2019 in conjunction with the MD&M East event in New York, New York.

Valeda® Light Delivery System

LumiThera, Inc. is a leader in the use of photobiomodulation for the treatment of acute and chronic ocular diseases and disorders. Age-related macular degeneration (AMD) is the leading cause of blindness in adults over 65. Product Creation Studio worked with LumiThera from product concept through transfer to manufacturing to design and engineer a medical device that would accurately, safely, and effectively treat patients suffering from dry AMD. The resulting Valeda Light Delivery System is currently the only approved treatment using Photobiomodulation … If you’ve never heard of this well researched and incredible technology to decrease inflammation and shorten healing time, watch our Podcast Video! PBM has successfully helped thousands of people in over 70 countries with chronic pain, macular degeneration, shingles pain, recovery from athletic injury, CTE, PTSD and more. Check out ThorLaser.com to connect with James, his research, and how THOR PBM can improve your life.”

Gut Check Project
Kenneth Brown, MD
Board Certified Gastroenterologist

View current photobiomodulation therapy training dates in your location.

Posted in Industry, Interviews, James in Action, THE FUTURE OF PBM/LLLT, Video of the Week | on Podcast interview of James Carroll by Gut Check Project

James Carroll’s Photobiomodulation and NovoTHOR interview

Posted on 4 April 2019 by Ian

Laser Therapy Sydney interviews James Carroll CEO and Founder of Thor Photomedicine and the NovoTHOR light-pod.

James Carroll sheds light on what Photobiomodulation is and what conditions it can treat; who is using it and how Thor products are different; oral mucositis and the opioid crisis; and the future of PBM in Australia.

View current photobiomodulation therapy training dates in your location.

Posted in Industry, Interviews, James in Action, THE FUTURE OF PBM/LLLT, Video of the Week | on James Carroll’s Photobiomodulation and NovoTHOR interview

Congressional Briefing Highlight Video

Posted on 20 March 2019 by Ian

U.S. CONGRESSIONAL BRIEFING. Ending Opioid Use – Washington DC

James Carroll presented evidence to Congress on the effectiveness of PBM for treating pain and where it can be used in place of opioids. Prof. Praveen Arany explained how and why it works, and Annette Quinn RN gave her first hand experience in treating over 854 patients with Oral Mucositis.

Learn more at CongressPBM.com

Watch James Carroll’s Congress speech on ending opioid use with Photobiomodulation

Read James Carroll’s Speech to Congress on citizenoversight.blogspot.com

View current photobiomodulation therapy training dates in your location.

More NovoTHOR Testimonials

Posted in Industry, James in Action, THE FUTURE OF PBM/LLLT, Video of the Week | on Congressional Briefing Highlight Video

LumiThera Receives Notice of Award for $2.5 Million National Eye Institute Grant to Support U.S. Multi-Center Clinical Trial for Treating Dry Age-Related Macular Degeneration

Posted on 27 February 2019 by James Carroll

LumiThera Inc., a commercial stage medical device company creating a photobiomodulation (PBM) treatment for ocular disorders and disease, today announced it is a recipient of a small business innovative research (SBIR) phase II grant from the National Institute of Health (NIH) and the division of the National Eye Institute (NEI).

Valeda™ Light Delivery System patient treatmentThe phase II grant supports a prospective, randomized, multi-center human clinical trial in U.S. subjects diagnosed with dry age-related macular degeneration (dry AMD.) The LIGHTSITE III trial, which is subject to FDA Investigational Device Exemption (IDE) approval, will test vision and examine disease pathology in the eye following PBM treatments using the Company’s Valeda™ Light Delivery System. Subjects will be followed for up to two years. In 2018, LumiThera obtained a CE mark to commercialize the Valeda™ Light Delivery System … Continue reading →

Posted in Industry | on LumiThera Receives Notice of Award for $2.5 Million National Eye Institute Grant to Support U.S. Multi-Center Clinical Trial for Treating Dry Age-Related Macular Degeneration